160 related articles for article (PubMed ID: 15134520)
21. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
Jiang ZJ; Richardson JS; Yu PH
Neuropathol Appl Neurobiol; 2008 Apr; 34(2):194-204. PubMed ID: 17971074
[TBL] [Abstract][Full Text] [Related]
22. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
[TBL] [Abstract][Full Text] [Related]
23. Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.
Murata M; Noda K; Kawasaki A; Yoshida S; Dong Y; Saito M; Dong Z; Ando R; Mori S; Saito W; Kanda A; Ishida S
Curr Eye Res; 2017 Dec; 42(12):1674-1683. PubMed ID: 28937866
[TBL] [Abstract][Full Text] [Related]
24. Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications.
Stolen CM; Madanat R; Marti L; Kari S; Yegutkin GG; Sariola H; Zorzano A; Jalkanen S
FASEB J; 2004 Apr; 18(6):702-4. PubMed ID: 14977883
[TBL] [Abstract][Full Text] [Related]
25. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications.
Yu PH; Zuo DM
Diabetologia; 1997 Nov; 40(11):1243-50. PubMed ID: 9389414
[TBL] [Abstract][Full Text] [Related]
26. Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats.
Li C; Wang Z; Li X; Chen J
BMC Endocr Disord; 2019 Jun; 19(1):59. PubMed ID: 31182088
[TBL] [Abstract][Full Text] [Related]
27. Some aspects of the pathophysiology of semicarbazide-sensitive amine oxidase enzymes.
Callingham BA; Crosbie AE; Rous BA
Prog Brain Res; 1995; 106():305-21. PubMed ID: 8584667
[TBL] [Abstract][Full Text] [Related]
28. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology.
Boomsma F; Bhaggoe UM; van der Houwen AM; van den Meiracker AH
Biochim Biophys Acta; 2003 Apr; 1647(1-2):48-54. PubMed ID: 12686107
[TBL] [Abstract][Full Text] [Related]
29. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase.
Langford SD; Trent MB; Balakumaran A; Boor PJ
Toxicol Appl Pharmacol; 1999 Mar; 155(3):237-44. PubMed ID: 10079209
[TBL] [Abstract][Full Text] [Related]
30. Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis.
Mészáros Z; Karádi I; Csányi A; Szombathy T; Romics L; Magyar K
Eur J Drug Metab Pharmacokinet; 1999; 24(4):299-302. PubMed ID: 10892891
[TBL] [Abstract][Full Text] [Related]
31. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure.
Boomsma F; de Kam PJ; Tjeerdsma G; van den Meiracker AH; van Veldhuisen DJ
Eur Heart J; 2000 Nov; 21(22):1859-63. PubMed ID: 11052858
[TBL] [Abstract][Full Text] [Related]
32. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells.
Hernandez M; Solé M; Boada M; Unzeta M
Biochim Biophys Acta; 2006 Feb; 1763(2):164-73. PubMed ID: 16448709
[TBL] [Abstract][Full Text] [Related]
33. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharide-induced pulmonary inflammation.
Yu PH; Lu LX; Fan H; Kazachkov M; Jiang ZJ; Jalkanen S; Stolen C
Am J Pathol; 2006 Mar; 168(3):718-26. PubMed ID: 16507887
[TBL] [Abstract][Full Text] [Related]
34. Alterations in plasma semicarbazide-sensitive amine oxidase activity in hypertensive heart disease with left ventricular systolic dysfunction.
Marinho C; Arduíno D; Falcão LM; Bicho M
Rev Port Cardiol; 2010 Jan; 29(1):37-47. PubMed ID: 20391898
[TBL] [Abstract][Full Text] [Related]
35. Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging.
del Mar Hernandez M; Esteban M; Szabo P; Boada M; Unzeta M
Neurosci Lett; 2005 Aug 12-19; 384(1-2):183-7. PubMed ID: 15894424
[TBL] [Abstract][Full Text] [Related]
36. Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in atherogenesis in KKAy diabetic mice fed with high cholesterol diet.
Yu PH; Wang M; Deng YL; Fan H; Shira-Bock L
Diabetologia; 2002 Sep; 45(9):1255-62. PubMed ID: 12242458
[TBL] [Abstract][Full Text] [Related]
37. Plasma semicarbazide-sensitive amine oxidase in stroke.
Garpenstrand H; Ekblom J; von Arbin M; Oreland L; Murray V
Eur Neurol; 1999 Jan; 41(1):20-3. PubMed ID: 9885324
[TBL] [Abstract][Full Text] [Related]
38. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine.
Gubisne-Haberle D; Hill W; Kazachkov M; Richardson JS; Yu PH
J Pharmacol Exp Ther; 2004 Sep; 310(3):1125-32. PubMed ID: 15128865
[TBL] [Abstract][Full Text] [Related]
39. Studies on semicarbazide-sensitive amine oxidase in patients with diabetes mellitus and in transgenic mice.
Göktürk C; Garpenstrand H; Nilsson J; Nordquist J; Oreland L; Forsberg-Nilsson K
Biochim Biophys Acta; 2003 Apr; 1647(1-2):88-91. PubMed ID: 12686114
[TBL] [Abstract][Full Text] [Related]
40. Serum semicarbazide-sensitive amine oxidase (SSAO) activity is an independent marker of carotid atherosclerosis.
Karádi I; Mészáros Z; Csányi A; Szombathy T; Hosszúfalusi N; Romics L; Magyar K
Clin Chim Acta; 2002 Sep; 323(1-2):139-46. PubMed ID: 12135815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
